<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564420</url>
  </required_header>
  <id_info>
    <org_study_id>Santos 2012</org_study_id>
    <nct_id>NCT01564420</nct_id>
  </id_info>
  <brief_title>Morphine Postoperative Analgesia and Pharmacokinetic/Pharmacodynamic Modeling</brief_title>
  <official_title>Pharmacokinetic/Pharmacodynamic Modeling of Morphine for Postoperative Analgesia Through a Patient Controlled Device After Coronary Artery Bypass Grafting. Intrathecal Morphine Significantly Reduces Drug Consumption</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The currently available data are insufficient to develop a model that achieves optimum
      morphine dose individualization at the postoperative period of coronary artery bypass
      grafting (CABG). Therefore, the objective of the study was to apply a PK/PD model that could
      justify morphine consumption, drug plasma concentration and pain intensity during the
      postoperative period after CABG and evaluate the post operative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol was a prospective, open-label study, approved by the institutional ethical
      committee of the hospital where the study was performed. Patients were randomly assigned to
      receive general anesthesia plus intrathecal morphine at a dosage of 400 mcg (morphine group)
      or general anesthesia alone (control group) according to a simple computer-generated list.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>two days</time_frame>
    <description>From the end of surgery until 36 hours of postoperative period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PK/PD modelling</measure>
    <time_frame>2 days</time_frame>
    <description>From the begin of surgery until 36 hours of postoperative period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PK parameter: Cmax (peak plasma concentration)</measure>
    <time_frame>2 days</time_frame>
    <description>from the begin of surgery until 36 hours of postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PK parameter: Tmax (time to achieve the maximum concentration)</measure>
    <time_frame>2 days</time_frame>
    <description>from the begin of surgery until 36 hours of postoperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PK parameter: AUC (area under the plasma cocentration versus time curve)</measure>
    <time_frame>2 days</time_frame>
    <description>from the begin of surgery until 36 hours of postoperative period</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">36</enrollment>
  <condition>Cardiopulmonar Artery Bypass Grafting</condition>
  <arm_group>
    <arm_group_label>Intrathecal morphine</arm_group_label>
    <description>Patients were randomized for general anesthesia, and allocated in the control group and morphine intrathecal group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      For pharmacokinetic analysis, a serial of blood samples of patients was collected
      postoperatively after the extubation from a venous catheter (5mL each) into an EDTA tube (BD,
      Sao Paulo/Brazil) in the periods as follows: 0, 0.08, 0.25, 0.5, 1, 3, 6, 12, 18, 24 and 36
      hrs. Blood samples were centrifuged at 2800 g for 20 minutes, plasma was transferred to
      labeled polyethylene vials and frozen at -80ºC until drug plasma assay.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary artery disease, eligible to cardiopulmonary artery bypass grafting
        surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  eligible to cardiopulmonary artery bypass grafting surgery

        Exclusion Criteria:

          -  fraction of ejection below 40%

          -  contraindications to neuraxial blockage

          -  coagulopathy

          -  use of low-weight heparin

          -  warfarin or a platelet aggregation inhibitor other than aspirin,

          -  systemic or local infection

          -  and patients with a specific contraindication on the medication employed in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia RCJ Santos, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Pharmaceutical Science</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.anestesiologiausp.com.br</url>
    <description>Group web site</description>
  </link>
  <link>
    <url>http://conselho.saude.gov.br/web_comissoes/conep/index.html</url>
    <description>Health national council web site</description>
  </link>
  <results_reference>
    <citation>dos Santos LM, Santos VC, Santos SR, Malbouisson LM, Carmona MJ. Intrathecal morphine plus general anesthesia in cardiac surgery: effects on pulmonary function, postoperative analgesia, and plasma morphine concentration. Clinics (Sao Paulo). 2009;64(4):279-85.</citation>
    <PMID>19488583</PMID>
  </results_reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2012</study_first_posted>
  <last_update_submitted>March 23, 2012</last_update_submitted>
  <last_update_submitted_qc>March 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Silvia Regina Cavani Jorge Santos</investigator_full_name>
    <investigator_title>Chair Professor</investigator_title>
  </responsible_party>
  <keyword>pharmacokinetic/pharmacodynamic modeling</keyword>
  <keyword>intrathecal morphine</keyword>
  <keyword>postoperative analgesia</keyword>
  <keyword>patient-controlled analgesia device</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

